dengu
caus
dengu
viru
denv
constitut
public
health
emerg
intern
concern
denv
infect
human
result
spectrum
outcom
rang
asymptomat
undifferenti
fever
mild
form
diseas
name
dengu
fever
df
sever
form
includ
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
may
fatal
outcom
denv
infect
determin
multipl
factor
includ
viral
virul
host
genet
host
immun
respons
among
variou
compon
host
immun
respons
cell
antibodi
cytokin
storm
complement
factor
contribut
pathogenesi
dengu
epidemiolog
studi
shown
associ
dhfdss
secondari
denv
infect
preexist
antibodi
cross
reactiv
cell
respons
induc
primari
infect
believ
exacerb
diseas
secondari
infect
proinflammatori
cytokin
name
tumor
necrosi
anti
inflammatori
cytokin
also
contribut
dengu
diseas
pathogenesi
activ
cell
antibodi
cytokin
influenc
variou
immunomodul
increas
decreas
level
immunomodul
influenc
outcom
viral
infect
vitamin
potent
immunomodul
affect
innat
adapt
immun
respons
vitamin
bind
vitamin
receptor
vdr
transloc
nucleu
influenc
gene
express
vitamin
enhanc
phagocyt
capac
macrophag
induc
antimicrobi
peptid
gene
express
contribut
innat
immun
respons
vitamin
inhibit
thelper
cell
cytotox
cell
respons
decreas
bcell
prolifer
plasmacel
differenti
igg
secret
vitamin
also
enhanc
cytokin
respons
vitamin
defici
increas
risk
cancer
tuberculosi
well
influenza
human
immunodefici
viru
infect
vitamin
report
influenc
express
denv
receptor
immun
cell
studi
vietnam
shown
associ
vitamin
receptor
gene
polymorph
suscept
dhf
one
major
pathway
complement
activ
initi
bind
viru
mannos
bind
lectin
mbl
mbl
pattern
recognit
molecul
recogn
specif
sugar
molecul
present
surfac
microorgan
includ
denv
point
mutat
gene
lead
reduc
concentr
function
oligom
genet
determin
variat
serum
concentr
mbl
shown
influenc
suscept
infecti
autoimmun
cardiovascular
diseas
allel
gene
associ
higher
concentr
function
mbl
shown
associ
thrombocytopenia
dengu
infect
patient
mbl
concentr
also
found
increas
acut
sampl
dhf
case
compar
df
case
sinc
mbl
vitamin
known
influenc
innat
adapt
immun
respons
denv
pathogenesi
immun
mediat
hypothes
alter
level
plasma
vitamin
mbl
might
associ
dengu
diseas
sever
therefor
investig
level
plasma
vitamin
mbl
dengu
infect
patient
context
diseas
sever
immun
statu
among
patient
includ
studi
base
dfdhf
defin
criteria
world
health
organ
df
dhf
male
repres
df
dhf
patient
male
femal
ratio
df
dhf
demograph
clinic
characterist
patient
given
tabl
median
age
dhf
case
year
significantli
lower
df
case
year
p
number
primari
case
df
higher
number
primari
case
dhf
p
presenc
clinic
symptom
compar
df
dhf
case
presenc
fever
chill
headach
myalgia
arthralgia
retro
orbit
pain
rash
report
equal
df
dhf
case
presenc
nauseavomit
abdomin
pain
repres
dhf
case
thrombocytopenia
significantli
repres
dhf
case
compar
df
case
p
median
count
platelet
significantli
lower
dhf
case
p
tabl
among
dhf
case
gastrointestin
bleed
manifest
melena
hematemesi
report
case
hematuria
observ
six
gum
bleed
seven
conjunctiv
hemorrhag
one
epistaxi
one
plasma
leakag
observ
patient
either
ascit
n
andor
pleural
effus
n
shockhypotens
observ
five
patient
fatal
observ
case
includ
studi
plasma
vitamin
vitamin
concentr
investig
df
case
dhf
case
healthi
control
vitamin
concentr
found
significantli
higher
df
dhf
case
compar
healthi
control
healthi
control
vs
df
case
p
healthi
control
vs
dhf
case
p
among
df
dhf
case
vitamin
concentr
found
higher
dhf
case
though
differ
statist
signific
p
figur
sampl
size
power
detect
differ
observ
dhf
healthi
control
df
healthi
control
respect
patient
group
base
immun
statu
diseas
sever
secondari
dhf
case
significantli
higher
concentr
vitamin
compar
secondari
df
case
p
sampl
size
power
detect
differ
observ
secondari
df
secondari
dhf
case
vitamin
concentr
significantli
differ
primari
df
primari
dhf
case
p
comparison
made
primari
df
secondari
df
primari
dhf
secondari
dhf
vitamin
level
differ
p
figur
plasma
mbl
concentr
assess
df
case
dhf
case
healthi
control
mbl
concentr
significantli
differ
healthi
control
df
dhf
case
p
df
dhf
case
compar
significantli
lower
concentr
mbl
observ
dhf
case
p
figur
sampl
size
power
detect
observ
differ
dhf
df
case
sampl
size
underpow
detect
differ
effect
size
less
observ
df
healthi
control
dhf
healthi
control
howev
sampl
size
power
detect
effect
size
patient
classifi
primari
secondari
case
compar
irrespect
df
dhf
mbl
concentr
differ
p
mbl
concentr
lower
primari
dhf
case
compar
primari
df
case
though
statist
signific
mbl
level
differ
secondari
df
secondari
dhf
figur
sinc
mbl
level
vari
function
multipl
polymorph
gene
cutoff
valu
ngml
use
defin
subject
without
mbl
defici
base
cutoff
valu
dhf
case
df
case
healthi
control
defici
mbl
patient
group
base
diseas
sever
immun
statu
primari
dhf
case
mbl
defici
compar
primari
df
case
p
odd
ratio
confid
limit
differ
observ
secondari
infect
secondari
df
secondari
dhf
patient
low
level
mbl
analysi
cutoff
valu
indic
almost
complet
defici
mbl
ngml
also
perform
result
reveal
primari
dhf
case
almost
complet
defici
mbl
compar
primari
df
case
p
ci
secondari
df
secondari
dhf
patient
almost
complet
defici
mbl
present
studi
plasma
concentr
vitamin
mbl
investig
dengu
patient
pune
maharashtra
western
india
pune
endem
dengu
case
occur
annual
four
serotyp
report
circul
pune
demograph
clinic
characterist
report
present
studi
similar
report
earlier
studi
investig
vitamin
concentr
reveal
significantli
higher
concentr
vitamin
dengu
patient
df
dhf
compar
appar
healthi
control
suggest
higher
concentr
vitamin
might
associ
symptomat
diseas
analysi
reveal
associ
evid
secondari
dhf
shown
vitamin
induc
express
dendrit
cell
specif
intercellular
adhes
molecul
grab
non
integrin
dcsign
primari
receptor
denv
entri
immatur
dendrit
cell
also
shown
calcitriol
activ
form
vitamin
increas
express
receptor
human
monocyt
cell
line
monocyt
deriv
dendrit
cell
increas
concentr
vitamin
denv
infect
case
secondari
infect
might
enhanc
viral
entri
increas
express
receptor
lead
higher
viral
load
uncontrol
inflammatori
respons
subsequ
develop
dhf
vitamin
also
known
suppress
cytokin
enhanc
product
peripher
blood
mononuclear
cell
respons
microbi
antigen
sinc
known
play
role
dengu
diseas
pathogenesi
possibl
vitamin
could
also
contribut
diseas
pathogenesi
alter
respons
sinc
effect
vitamin
also
depend
singl
nucleotid
polymorph
vdr
gene
influenc
vitamin
dengu
context
host
genet
need
investig
analysi
circul
concentr
mbl
dengu
case
healthi
control
reveal
signific
differ
two
group
suggest
mbl
mediat
pathway
complement
activ
might
inhibit
may
induc
denv
infect
defici
mbl
report
patient
infect
rna
virus
crimeancongo
hemorrhag
fever
viru
respiratori
syncyti
viru
sever
acut
respiratori
syndrom
sar
corona
viru
interact
complement
compon
non
structur
protein
flavivirus
report
inhibit
classic
lectin
pathway
complement
activ
present
studi
reveal
significantli
lower
level
mbl
dhf
case
suggest
reduc
activ
mbl
mediat
complement
pathway
might
associ
dhf
mbl
known
interact
n
link
glycan
structur
protein
denv
neutral
viru
block
viral
fusion
experiment
infect
mice
mbl
depend
intravascular
clearanc
denv
also
report
therefor
possibl
mbl
defici
might
led
decreas
activ
mbl
mediat
pathway
complement
reduc
intravascular
clearanc
denv
lead
higher
viral
load
higher
viral
load
shown
associ
dhf
sever
studi
present
studi
defici
mbl
evid
case
primari
dhf
associ
mbl
defici
dhf
primari
infect
also
suggest
protect
effect
mbl
innat
immun
respons
import
primari
infect
could
overshadow
presenc
cross
reactiv
complement
fix
antibodi
secondari
infect
contrast
present
studi
studi
brazil
report
higher
concentr
mbl
among
dhf
case
higher
mbl
concentr
might
also
lead
increas
inflamm
enhanc
product
proinflammatori
cytokin
increas
concentr
factor
decreas
concentr
factor
h
report
dhf
case
suggest
imbal
regul
factor
h
altern
pathway
complement
activ
associ
dhf
sinc
mbl
concentr
depend
presenc
mutat
structur
promot
region
gene
possibl
variant
allel
gene
polymorph
might
associ
dhf
case
control
studi
brazil
shown
associ
wild
type
allel
gene
thrombocytopenia
dengu
patient
case
control
studi
need
confirm
phenotyp
effect
gene
polymorph
dengu
patient
primari
infect
india
although
present
studi
suffici
power
detect
intermedi
larg
effect
size
regard
mbl
studi
underpow
studi
larger
sampl
size
need
confirm
preliminari
associ
present
studi
suggest
higher
concentr
vitamin
associ
secondari
dhf
associ
may
relat
induc
effect
vitamin
receptor
express
might
subsequ
lead
higher
viral
load
dengu
case
secondari
infect
henc
develop
dhf
studi
also
suggest
mbl
defici
associ
primari
dhf
associ
might
relat
reduc
activ
mbl
pathway
complement
lead
higher
viral
load
dengu
case
primari
infect
first
studi
correl
concentr
vitamin
mbl
immun
statu
dengu
case
blood
sampl
patient
dengu
like
ill
refer
nation
institut
virolog
diagnosi
sampl
transport
ice
plasma
separ
aliquot
one
aliquot
use
dengu
specif
igm
elisa
leftov
aliquot
store
total
number
sampl
posit
dengu
specif
igm
elisa
includ
studi
sampl
collect
season
outbreak
pune
clinic
present
patient
record
clinician
use
classifi
patient
patient
classifi
df
dhf
patient
fever
headach
myalgia
retroorbit
pain
rash
defin
df
dhf
patient
categor
presenc
least
two
dhf
defin
criteria
hemorrhag
tendenciesmanifest
thrombocytopenia
evid
plasma
leakag
sampl
appar
healthi
blood
donor
also
use
studi
studi
approv
nation
institut
virolog
human
ethic
committe
waiver
inform
consent
grant
committe
basi
use
leftov
specimen
clinic
investig
indian
council
medic
research
guidelin
inhous
nation
institut
virolog
niv
igm
captur
elisa
kit
use
detect
denvspecif
igm
known
posit
p
known
neg
n
serum
control
use
everi
test
sampl
show
pn
ratio
time
optic
densiti
consid
posit
igg
captur
elisa
panbio
windsor
australia
use
classifi
case
primari
secondari
denv
infect
igg
level
unit
defin
manufactur
indic
secondari
infect
vitamin
quantit
plasma
sampl
use
enzym
immunoassay
kit
id
ltd
uk
accord
manufactur
protocol
calibr
control
use
assay
percent
bind
bb
calibr
control
unknown
sampl
calcul
follow
formula
bb
mean
absorbancemean
absorb
calibr
calibr
curv
bb
vitamin
concentr
use
find
concentr
vitamin
unknown
sampl
nml
detect
limit
kit
nml
estim
plasma
mbl
concentr
done
use
mbl
oligom
elisa
kit
bioporto
diagnost
denmark
accord
manufactur
instruct
calibr
use
assay
calibr
curv
construct
plot
mean
absorb
valu
calibr
yaxi
correspond
mbl
concentr
ngml
xaxi
mbl
concentr
dilut
plasma
sampl
found
locat
point
curv
correspond
absorb
valu
dilut
plasma
sampl
read
correspond
concentr
ngml
xaxi
concentr
mbl
undilut
plasma
sampl
calcul
multipli
result
sampl
dilut
factor
detect
limit
kit
ngml
use
statcalc
program
epi
info
version
cdc
atlanta
ga
juli
chisquar
test
yate
correct
fisher
exact
test
cell
valu
less
perform
examin
differ
demograph
clinic
characterist
dengu
patient
age
platelet
count
compar
use
u
test
concentr
mbl
oh
plasma
sampl
compar
studi
group
use
kruskalw
test
dunn
multipl
comparison
select
group
p
valu
dunn
multipl
comparison
select
group
provid
sinc
mbl
level
vari
depend
presenc
polymorph
gene
categor
studi
subject
base
mbl
defici
defin
cutoff
valu
ngml
done
compar
studi
group
use
chisquar
test
yate
correct
fisher
exact
test
cutoff
valu
ngml
earlier
shown
reliabl
predictor
low
produc
genotyp
use
receiv
oper
characterist
analysi
individu
data
healthi
subject
studi
statist
analysi
perform
use
graphpad
prism
version
two
tail
p
valu
less
consid
signific
power
calcul
perform
use
softwar
g
power
version
achiev
power
signific
result
calcul
use
test
two
group
option
avail
test
famili
softwar
sampl
size
level
signific
effect
size
provid
input
calcul
effect
size
softwar
use
mean
valu
standard
deviat
two
group
denv
dengu
viru
df
dengu
fever
dhf
dengu
hemorrhag
fever
dss
dengu
shock
syndrom
il
interleukin
tnf
tumour
necrosi
factor
ifn
interferon
vdr
vitamin
receptor
mbl
mannos
bind
lectin
vitamin
vitamin
odd
ratio
dcsign
dendrit
cell
specif
intercellular
adhes
molecul
th
helper
sar
sever
acut
respiratori
syndrom
p
posit
n
neg
author
declar
compet
interest
conceiv
design
experi
cd
ka
pss
perform
experi
ka
rvb
abb
analyz
data
ka
coordin
sampl
collect
diagnosi
pss
wrote
paper
ka
cd
author
read
approv
final
manuscript
